CLINICAL_TRIALS
trial_result
· 2018-06-15
Clinical Trial Update: Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson [Phase 4]
Summary
Phase 4 clinical trial update on a PET-MR myocardial perfusion examination using Regadenoson; the study is completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Ischemic Heart Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-06-15